|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2010-11-16
|
|
pubmed:abstractText |
Interferon (IFN) beta is a safe and efficient drug for treating multiple sclerosis (MS). It is widely accepted that previously depressed patients may get worse when using IFN-beta. There are few reports on the association of IFN-beta and severe depression among patients without previous psychiatric history.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1537-162X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
312-6
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21079457-Adult,
pubmed-meshheading:21079457-Brazil,
pubmed-meshheading:21079457-Depressive Disorder,
pubmed-meshheading:21079457-Drug Monitoring,
pubmed-meshheading:21079457-Female,
pubmed-meshheading:21079457-Humans,
pubmed-meshheading:21079457-Interferon Type I,
pubmed-meshheading:21079457-Male,
pubmed-meshheading:21079457-Middle Aged,
pubmed-meshheading:21079457-Mood Disorders,
pubmed-meshheading:21079457-Multiple Sclerosis,
pubmed-meshheading:21079457-Prevalence,
pubmed-meshheading:21079457-Recombinant Proteins,
pubmed-meshheading:21079457-Suicidal Ideation,
pubmed-meshheading:21079457-Suicide, Attempted,
pubmed-meshheading:21079457-Treatment Outcome,
pubmed-meshheading:21079457-Young Adult
|
|
pubmed:articleTitle |
Severe depression, suicide attempts, and ideation during the use of interferon beta by patients with multiple sclerosis.
|
|
pubmed:affiliation |
Universidade Metropolitana de Santos, São Paulo, Brazil. yara@bsnet.com.br
|
|
pubmed:publicationType |
Journal Article,
Review,
Case Reports
|
